Copper and Molybdenum Balance in Participants With Wilson Disease Treated With ALXN1840
Clinical trial NCT04573309 · COMPLETED
Trial details
- NCT number
- NCT04573309
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-07
- Primary completion
- 2022-06-07
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.